Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses than that of the Partially Effective gB/MF59 Vaccine

Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, Sarah M. Valencia, Jennifer A. Jenks, Helen Webster, Itzayana G. Miller, Megan Connors, Justin Pollara, Caroline Andy, Linda M. Gerber, Emmanuel B. Walter, Kathryn M. Edwards, David I. Bernstein, Jacob Hou, Matthew Koch, Lori Panther, Andrea Carfi, Kai Wu, Sallie R. Permar
doi: https://doi.org/10.1101/2023.08.02.23293386
Back to top
Posted August 06, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses than that of the Partially Effective gB/MF59 Vaccine
Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, Sarah M. Valencia, Jennifer A. Jenks, Helen Webster, Itzayana G. Miller, Megan Connors, Justin Pollara, Caroline Andy, Linda M. Gerber, Emmanuel B. Walter, Kathryn M. Edwards, David I. Bernstein, Jacob Hou, Matthew Koch, Lori Panther, Andrea Carfi, Kai Wu, Sallie R. Permar
medRxiv 2023.08.02.23293386; doi: https://doi.org/10.1101/2023.08.02.23293386
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area